FDA approves first treatment for peanut allergy
February 3, 2020Sales and Marketing FDA, FDA Peanuts, peanut, peanut allergy, peanut medicine
The FDA has approved its first treatment for peanut allergy in patients between ages four and 17. The drug is …
AI firm Exscientia appoints COO and Head of Drug Discovery
January 31, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exscientia, appointment
AI drug discovery firm Exscientia has announced the appointment of Dr David Hallett as its Chief Operating Officer and Head …
NHS Chief Simon Stevens: Gwyneth Paltrow’s Goop poses “considerable risks to health”
January 31, 2020Medical Communications Goop, Gwyneth Platrow, NHS, Simon Stevens, pharma
NHS Chief Executive Simon Stevens has gone head-to-head with Hollywood actor and “wellness guru” Gwyneth Paltrow, taking aim at her …
Top Ten most popular articles on Pharmafile.com this week
January 31, 2020Medical Communications Janseen, Ketamine, NHS, NICE, Nasal sprays, Nasl, Top 10 of the week, top 10
This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s …
Two coronavirus cases in the UK as WHO declare outbreak as a ‘global emergency’
January 31, 2020Medical Communications Chinese Coronavirus, MERS, Wuhan Coronavirus, coronavirus, sara
Two people have tested positive for the Wuhan coronavirus in the UK, they are both part of the same family …
Bayer and Orion’s Nubeqa shows off strong overall survival benefit in castration-resistant prostate cancer
January 31, 2020Medical Communications, Research and Development Bayer, orion, pharma
Bayer and Finnish pharma firm Orion Corporation have announced positive new Phase 3 data for their jointly developed oral androgen …
Exscientia creates first drug using AI
January 31, 2020Medical Communications AI, AI healthcare, ai pharma
Exscientia has created a new OCD drug using artificial intelligence to sift through potential compounds, checking them against a huge …
Read the January/February 2020 edition of Pharmafocus online now!
January 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma
Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …
FDA warns Purell not to claim sanitizers prevent Ebola
January 30, 2020Business Services Ebola, Ebola africa, Ebola vaccine, hand sanitiser
The FDA has issued a warning letter to Purcell telling them to stop its misleading advertising of their sanitiser products. …
Healthy cells in lungs can repair the damage from smoking
January 30, 2020Business Services Cancer smoking, cigarettes, lung cancer, lungs, smoking
Human lungs have the ‘magical’ ability to repair the cancerous mutations caused by smoking cigarettes, but only if people quit …
Spring Bank Pharma shuts down HBV drug development following patient death
January 30, 2020Research and Development Spring Bank, patient death, pharma
Biopharma firm Spring Bank Pharmaceuticals has revealed it has taken the decision to terminate all further development of inarigivir soproxil …
Johnson & Johnson working on coronavirus vaccine
January 30, 2020Business Services, Research and Development Chinese Coronavirus, Wuhan Coronavirus, Wuhan epidemic, coronavirus
Johnson & Johnson has become the latest pharmaceutical company to begin work on a vaccine for the Chinese coronavirus. They …
Allergan opens new Botox plant in Westport
January 29, 2020Research and Development AbbVie Ireland, Allergan AbbVie, Allergan. Abbvie
Allergan has officially opened a new €145m facility in Westport, Ireland to boost production of Botox. The new building rxpands …
Janssen’s Erleada expanded in Europe to cover metastatic hormone-sensitive prostate cancer
January 29, 2020Research and Development, Sales and Marketing Erleada, Europe, Janssen, pharma
Janssen’s Erleada (apalutamide) has secured expanded authorisation from the European Commission (EC), approving its label to include the treatment of …
BioIntelliSense’ BioSticker sensor approved by the FDA
January 29, 2020Research and Development Biosticker, home care, sensors
BioIntelliSense has secured 510 (k) clearance from the FDA for its biosticker sensor for remote care. The product is an …
FDA approves Teva’s Ajovy autoinjector for treatment of migraine
January 29, 2020Research and Development, Sales and Marketing FDA, Teva, ajovy, migraine, pharma
Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …
British Airways suspends all flights to mainland China
January 29, 2020Research and Development British Airways, MERS, Sars, Wuhan Virus, coronavirus, virus
British Airways has ceased all flights to mainland China until 31 January. This comes after the Foreign Office advice against …
Prostate Cancer becomes most commonly diagnosed cancer in England
January 28, 2020Manufacturing and Production Cancer, Cancer diagnoses, NHS England, breast cancer, prostate cancer
Prostate cancer has overtaken breast cancer to be the most commonly diagnosed cancer for the first time in England, latest …
Lilly & Incyte’s Olumiant hits main goal in atopic dermatitis
January 28, 2020Manufacturing and Production, Research and Development Eli Lilly, Olumiant, pharma
Eli Lilly and Incyte have lifted the curtain on new Phase 3 data showing that their oral JAK inhibitor, showing …
Johnson & Johnson CEO testifies for the first time in Baby Powder Cancer trial
January 28, 2020Manufacturing and Production J&J, JJ, Johnson & Johnson, Talc Powder Cancer, baby powder, talc powder
Johnson & Johnson CEO Alex Gorsky faced questions around stock sales and his knowledge of asbestos in the company’s baby …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
